Medical Advocates
HCV Infection/Disease

Main Page

New/Noteworthy
HCV Videos
FDA Recalls
Guidelines
General Reports
Pathogenesis
Virology
Special Populations
Natural History
Screening
Risk Factors
Clinical Variants
Coinfections Extrahepatic Manifestations
Epidemiology/Nat'l Studies
Oncology
Diagnostics
Treatment
Drugs
Patient Perspectives
Quality of Life
Prevention
Vaccinations
Links

Home Page Main New/Newsworthy Disease Index

Last Update: March 10, 2010
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

March 2010

Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic
Hepatitis C Virological Responders: A Pilot Study of 7 Cases.
Akuta N, Suzuki F, Arase Y, et al Intervirology. 2010 Mar 3;53(3):188-192

February 2010

17th CROI

POSTER
Declining Hepatitis C Virus (HCV) Incidence Over 20 Years among HIV Positive and Negative
Injection Drug Users (IDU) in Baltimore, MD (1988 to 2008)
S Mehta, J Astemborski, G Kirk, et al
PDF Poster Abstract

POSTER
Influence of HAART on Hepatitis C Virus Escape from CD8⁺ T Cell Immune Pressure
J Rohrbach, M Tschochner, A Chopra, et al
PDF Poster Abstract

Molecular Epidemiology of HCV Genotypes Among Injection Drug Users in Taiwan: Identification
of A New Subtype 6v and Unique Recombinant Form_2b6v
Y-M Lee, H-J Lin Y-J Chen, et al

Survival of HCV in Syringes: Implication for HCV Transmission among Injection Drug Users
E Paintsil, H He, C Peters, et al

Journal Citations

Institute of Medicine recommendations for the prevention and control of hepatitis B and C.
|Mitchell AE, Colvin HM, Palmer Beasley R.Hepatology. 2010 Feb 22;51(3):729-733.
Utilization and Antiviral Therapy in Patients with Chronic Hepatitis C:
Analysis of Ambulatory Care Visits in the US.
Cheung R, Mannalithara A, Singh G, et al Dig Dis Sci. 2010 Feb 26.

Hepatitis C virus infection in a Japanese leprosy sanatorium for the past 67 years.
Shiogama K, Teramoto H, Morita Y, et al J Med Virol. 2010 Feb 17;82(4):556-561

Reduction of Insulin Resistance with Effective Clearance of Hepatitis C Infection:
Results from the Halt-C Trial.
Delgado-Borrego A, Jordan SH, et al Clin Gastroenterol Hepatol. 2010 Feb 12

Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin,
for the treatment of HCV infection.
Watashi K.Curr Opin Investig Drugs. 2010 Feb;11(2):213-24.

Impaired cognitive function in hepatitis C - a review.
Renvillard SG, Leutscher PD, Hjerrild S, Videbech P.Ugeskr Laeger. 2010 Feb 1;172(5):372-376

Management of Acute Hepatitis C.
Maheshwari A, Thuluvath PJ. Clin Liver Dis. 2010 Feb;14(1):169-176.

Health Care-Associated Transmission of Hepatitis B & C Viruses in Dental Care (Dentistry).
Younai FS.Clin Liver Dis. 2010 Feb;14(1):93-104.

Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new
hepatitis C virus infections.
Mostafa A, Taylor SM, El-Daly M, et al Liver Int. 2010 Jan 29.

Complete blood count, measures of iron status and inflammatory markers in
inner-city African Americans with undiagnosed Hepatitis C seropositivity.
Ufearo H, Kambal K, Onojobi GO, et al Clin Chim Acta. 2010 Jan 28

Antiviral therapy for chronic hepatitis C: current status and perspectives.
Takehara T. Yakugaku Zasshi. 2010 Feb;130(2):143-56.

Impact of international consensus guidelines on antiviral therapy of chronic hepatitis
C patients in Switzerland.
Overbeck K, Dufour JF, M�llhaupt B, et al Swiss Med Wkly. 2010 Feb 3

An updated follow-up of chronic hepatitis C after three decades of observation
in pediatric patients cured of malignancy.
Cesaro S, Bortolotti F, Petris MG, et al Pediatr Blood Cancer. 2010 Feb 1

Chronic hepatitis C - Assessment in civil law: A case study. [Portugal]
Santos BM, Sousa P, Mena F, et alJ Forensic Leg Med. 2010 Feb;17(2):99-101.

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system.
Jones CT, Catanese MT, Law LM, et alNat Biotechnol. 2010 Jan 31

Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C
virus genotyping.
Sohn YH, Ko SY, Kim MH, Oh HB.Clin Chem Lab Med. 2010 Feb 4

Guidelines

Internet Documents

FULL-TEXT GUIDELINES
Chronic Hepatitis C: Current Disease Management
The National Institute of Diabetes and Digestive and Kidney Diseases
Guidelines

Hepatitis C: What Clinicians and Other Health Professionals Need to Know
Training Module

Conference Reports, Abstracts, and Posters

CONFERENCE PRESENTATION
Draft NIH Consensus Statement on the Management of Hepatitis C
[NIH Consensus Development Conference on Management of Hepatitis C: 2002]
Report

General Reports

Internet Documents
	FULL-TEXT REPORT An Interview with Melissa Palmer, MD on her book, Dr. Melissa Palmer's Guide to Hepatitis & Liver Disease. Nary G Thoughtleaders August 2004 Vo 2 No 1 Interview

Journal Papers, Abstracts, and Commentaries

Viral hepatitis and HIV Co-Infection.
Soriano V, Vispo E, Labarga P, et al
Antiviral Res. 2009 Oct 31.
Abstract

Meta-Analysis: Increased Mortality Associated with Hepatitis C in HIV-Infected Persons
Is Unrelated to HIV Disease Progression.
Chen TY, Ding EL, Seage Iii GR, Kim AY.
Clin Infect Dis. 2009 Oct 20
Abstract

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.
Morin T, Pariente A, Lahmek P, et al
Eur J Gastroenterol Hepatol. 2009 Sep 3.
Abstract

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak
memory CD4 T-cell responses to hepatitis C virus.
Schnuriger A, Dominguez S, Guiguet M, et al
AIDS. 2009 Aug 25.
Abstract

Ethnicity and Body Mass Index are Associated with Hepatitis C Presentation and
Progression.
Kallwitz ER, Layden-Almer J, Dhamija M, et al
Clin Gastroenterol Hepatol. 2009 Aug 14
Abstract

Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase:
do they exist and is this really a group with mild disease?
Lawson A; on behalf of the Trent Hepatitis C Study Group.
J Viral Hepat. 2009 Jul 28.
Abstract

Effect of hepatitis C virus and its treatment on survival.
Butt AA, Wang X, Moore CG.
Hepatology. 2009 Jul 9.
Abstract

Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study
of patients with chronic viral C hepatitis.
Acalovschi M, Buzas C, Radu C, Grigorescu M.
J Viral Hepat. 2009 May 26.
Abstract

Hepatitis C virus and alcohol.
Siu L, Foont J, Wands JR.
Semin Liver Dis. 2009 May;29(2):188-99.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Adherence to medication for chronic hepatitis C: Building on the model of human immunodeficiency
virus antiretroviral adherence research.
Weiss JJ, Br�u N, Stivala A, et al
Aliment Pharmacol Ther. 2009 Mar 26.
Abstract

Hepatitis After Intravenous Injection of Sublingual Buprenorphine in Acute Hepatitis C Carriers:
Report of Two Cases of Disappearance of Viral Replication After Acute Hepatitis (May).
Peyri�re H, Tatem L, Bories C, et al
Ann Pharmacother. 2009 Apr 21.
Abstract

Transplantation of kidneys from HBV-positive or HCV-positive donors.
Xie X, Lan G, Peng L, Peng F, Wang Y, Fang C, Nie M.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Mar;34(3):259-63
Abstract

Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis
and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L, Spicher VM, Negro F, et al
J Viral Hepat. 2009 Feb 23
Abstract

FULL-TEXT ARTICLE
Evidence of recombination in intrapatient populations of hepatitis C virus.
Sentandreu V, Jim�nez-Hern�ndez N, Torres-Puente M, et al
PLoS ONE. 2008 Sep 18;3(9):e3239.
Paper

Intranasal Transmission of Hepatitis C Virus: Virological and Clinical Evidence.
Aaron S, McMahon JM, Milano D, et al
Clin Infect Dis. 2008 Sep 2.
Abstract

Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
Hiroishi K, Ito T, Imawari M.
J Gastroenterol Hepatol. 2008 Aug 28.
Abstract

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
Jonsson JR, Barrie HD, O'Rourke P, et al
Hepatology. 2008 Mar 3;48(1):80-87.
Abstract

"Look, I'm fit, I'm positive and I'll be all right, thank you very much": Coping with hepatitis C treatment and
unrealistic optimism.
Treloar C, Hopwood M.
Psychol Health Med. 2008 May;13(3):360-6.
Abstract

FULL TEXT ARTICLE
Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of
HCV genotype.
Abdoul H, Mallet V, Pol S, Fontanet A.
PLoS ONE. 2008 Jun 11;3(6):e2391.
Paper

Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France.
Deuffic-Burban S, Deltenre P, Louvet A, et al
J Hepatol. 2008 May 20.
Abstract

Immune responses during acute and chronic infection with hepatitis C virus.
Ishii S, Koziel MJ.
Clin Immunol. 2008 May 29.
Abstract

Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
Shores NJ, Maida I, Soriano V, N�ňez M.
J Hepatol. 2008 May 5.
Abstract

Acute hepatitis C: a systematic review.
Kamal SM.
Am J Gastroenterol. 2008 May;103(5):1283-97;
Abstract

Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide
community-based register study.
Duberg AS, T�rner A, Davi�sd�ttir L, et al
J Viral Hepat. 2008 Apr 4
Abstract

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral
therapy.
Mosley JW, Operskalski EA, Tobler LH, et al
J Viral Hepat. 2008 Feb;15(2):120-8.
Abstract

Estimating past hepatitis C infection risk from reported risk factor histories: implications for
imputing age of infection and modeling fibrosis progression.
Bacchetti P, Tien PC, Seaberg EC, et al
BMC Infect Dis. 2007 Dec 10;7(1):145
Paper

FULL TEXT ARTICLE
The hepatitis C sequence database in Los Alamos.
Kuiken C, Hraber P, Thurmond J, Yusim K.
Nucleic Acids Res. 2007 Nov 19
Paper

Spontaneous Recovery in Acute Human HCV Infection: Functional T Cell Thresholds
and Relative Importance of CD4 Help.
Smyk-Pearson S, Tester IA, et al
J Virol. 2007 Nov 28
Abstract

Hepatitis C Virus Infection: Sexual or Non-Sexual Transmission Between Spouses?
A Case Report and Review of the Literature.
Orlando R, Lirussi F.
Infection. 2007 Sep 28;
Abstract

HCV and diabetes A two question-based reappraisal.
Lonardo A, Carulli N, Loria P.
Dig Liver Dis. 2007 Jul 2;
Abstract

FULL TEXT PDF ARTICLE
Alcohol and hepatitis C.
Duggan JM, Duggan AE.
Med J Aust. 2007 Jul 2;187(1):47-8.
Commentary

Hepatitis C videoconferencing: the impact on continuing medical education for rural healthcare
providers.
Rossaro L, Tran TP, Ransibrahmanakul K, et al
Telemed J E Health. 2007 Jun;13(3):269-78.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT ARTICLE
Hepatitis C virus: Virology, diagnosis and management of antiviral therapy.
Chevaliez S, Pawlotsky JM.
World J Gastroenterol. 2007 May 7;13(17):2461-6
Paper

FULL TEXT ARTICLE
Hepatitis C virus proteins.
Dubuisson J.
World J Gastroenterol. 2007 May 7;13(17):2406-15.
Paper

FULL TEXT ARTICLE
Cell culture systems for the hepatitis C virus.
Duverlie G, Wychowski C.
World J Gastroenterol. 2007 May 7;13(17):2442-5.
Paper

Anger experiences among hepatitis C patients: relationship to depressive symptoms and
health-related quality of life.
Dan AA, Crone C, Wise TN, Martin LM, et al
Psychosomatics. 2007 May-Jun;48(3):223-9.
Abstract

Prevalence of Risk Factors for Hepatitis C Virus in HIV-Infected and HIV/Hepatitis C Virus-
Coinfected Patients.
Bollepalli S, Mathieson K, Bay C, et al
Sex Transm Dis. 2006 Sep 28;|
Abstract

Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C.
Castera L, Constant A, Bernard PH, et al
J Viral Hepat. 2006 Jul;13(7):482-8.
Abstract

Risk factors for HIV infection among patients infected with hepatitis C virus.
Silva AC, Barone AA.
Rev Saude Publica. 2006 Jun;40(3):482-8.
Abstract

Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-
monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.
Thein H, Maruff P, Krahn M, et al
HIV Med. 2007 Apr;8(3):192-202.
Abstract

Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. [US]
Campos NG, Salomon JA, Servoss JC, et al
Am J Med. 2007 Mar;120(3):272-9.
Abstract

Compensation of victims of nosocomial or post-transfusion hepatitis C virus infection. [France]
Manaouil C, Capron D, Nguyen-Khac ER, Jarde O.
Gastroenterol Clin Biol. 2007 Feb;31(2):185-94.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Occult hepatitis C virus infection: A new form of hepatitis C.
Carre�o V
World J Gastroenterol. 2006 Nov 21;12(43):6922-6925.
Paper

FULL TEXT PDF ARTICLE
Correlates of HCV seropositivity among familial contacts of HCV positive patients.
La Torre G, Miele L, Mannocci A, et al
BMC Public Health. 2006 Sep 25;6(1):237
Paper

Hepatitis C, metabolic syndrome, and inflammatory markers: Results from the Third National
Health and Nutrition Examination Survey [NHANES III].
Shaheen M, Echeverry D, Oblad MG, et al
Diabetes Res Clin Pract. 2006 Aug 16;
Abstract

Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients.
Pastore L, Fiore JR, Tateo M, et al
Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):217-24
Abstract

Eligibility for treatment of hepatitis C virus infection among young injection drug users in
3 US cities.
Hagan H, Latka MH, Campbell JV, et al
Clin Infect Dis. 2006 Mar 1;42(5):669-72
Abstract

Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and
HIV/HCV-co-infected veterans.
Goulet JL, Fultz SL, McGinnis KA, Justice AC.
AIDS. 2005 Oct;19 Suppl 3:S99-S105.
Abstract

Psychological implications of hepatitis C virus diagnosis.
Gill ML, Atiq M, Sattar S, Khokhar N.
J Gastroenterol Hepatol. 2005 Nov;20(11):1741-4
Abstract

Emerging evidence of hepatitis C virus neuroinvasion.
Lakus T, Radkowski M, Adair DM,
AIDS. 2005 Oct;19 Suppl 3:S140-4.
Abstract

FULL-TEXT REPORT
Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.
Ko WS, Guo CH, Yeh MS, Lin LY, et al
World J Gastroenterol. 2005 Aug 14;11(30):4697-702
Abstract

Risk factors for the acquisition of hepatitis C.
Bergk A, Berg T, Neumann UP.
Minerva Gastroenterol Dietol. 2005 Mar;51(1):7-1
Abstract

FULL-TEXT REPORT
Biopsychosocial Predictors of Health-Related Quality of Life in Patients With Chronic
Hepatitis C.
Hauser W, Zimmer C, Schiedermaier P, Grandt D.
Psychosom Med. 2004 Nov;66(6):954-958.
Paper

Receiving a hepatitis C-positive diagnosis.
Hopwood M, Treloar C.
Intern Med J. 2004 Sep;34(9-10):526-31.
Abstract

FULL-TEXT ARTICLE
Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.
Pham TN, MacParland SA, Mulrooney PM
J Virol. 2004 Jun;78(11):5867-74.
Paper

Burden of illness of hepatitis C from a managed care organization perspective.
Armstrong EP, Charland SL.
Curr Med Res Opin. 2004 May;20(5):671-9.
Abstract

Hepatitis B and C virus infection and the risk of atherosclerosis in a general population.
Volzke H, Schwahn C, Wolff B
Atherosclerosis. 2004 May;174(1):99-103.
Abstract

High body mass index is an independent risk factor for nonresponse to antiviral
treatment in chronic hepatitis C.
Bressler BL, Guindi M, Tomlinson G, Heathcote J.
Hepatology. 2003 Sep;38(3):639-44.
Abstract

Quality of life and cognitive function in hepatitis C at different stages
of liver disease.
Cordoba J, Flavia M, Jacas C, et al
J Hepatol. 2003 Aug;39(2):231-238.
Abstract

Rheumatic manifestations of hepatitis C infection.
Vassilopoulos D, Calabrese LH.
Curr Rheumatol Rep 2003 Jun;5(3):200-4
Abstract

Understudied populations with hepatitis C.
Strader DB.
Hepatology 2002 Nov;36(5):S226-S236
Abstract

Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis.
Maillefert JF, Muller G, Falgarone G, et al
Ann Rheum Dis 2002 Jul;61(7):635-637
Abstract

Conference Reports, Abstracts, and Posters

What's new in hepatitis C?
V Soriano
Ninth International Congress on Drug Therapy in HIV Infection
PDF Abstract

CD8-independent T cell populations dominate the immune response against HCV
V. Kasprowicz , Y.-H. Kang , B.E. Nolan , et al
(XVII International AIDS Conference)
Abstract

Pathogenesis

Journal Papers, Abstracts, and Commentaries

Virology and pathogenesis of hepatitis C virus recurrence.
Ram�rez S, P�rez-Del-Pulgar S, Forns X.
Liver Transpl. 2008 Oct;14 Suppl 2:S27-35.
Abstract

Pathogenesis of hepatitis C virus infection.
Kohla M, Bonacini M. et al
Minerva Gastroenterol Dietol. 2006 Jun;52(2):107-23
Abstract

Conference Reports, Abstracts, and Posters

Immunopathogenesis of Acute and Chronic Viral Hepatitis C
B Rehermann
(14 CROI)
Abstract

Virology

Journal Papers, Abstracts, and Commentaries

Hepatitis C Viral Kinetics in Special Populations.
Dahari H, Layden-Almer JE, Perelson AS, Layden TJ.
Curr Hepat Rep. 2008;7(3):97-105.
Abstract

Virology and pathogenesis of hepatitis C virus recurrence.
Ram�rez S, P�rez-Del-Pulgar S, Forns X.
Liver Transpl. 2008 Oct;14 Suppl 2:S27-35.
Abstract

FULL-TEXT ARTICLE
Molecular Virology of Hepatitis C Virus (HCV): 2006 Update.
Brass V, Moradpour D, Blum HE.
Int J Med Sci. 2006;3(2):29-34
Paper

Hepatitis C-virus - virus kinetics and resistance mechanisms
Herrmann E, Sarrazin C.
Z Gastroenterol. 2004 May;42(5):387-96
Abstract

Conference Reports, Abstracts, and Posters

POSTER
Hepatitis C Viral Kinetics: Changes in HCV Viral Load during the First 2 Weeks Are
Associated with Virologic Response but Are Not Affected by HIV Status
M Jain, J Shelton, A Reeck, et al
(14 CROI)
PDF Poster Abstract

POSTER
Genetic and Phenotypic Structure of Hepatitis C Virus NS3/4 Protease Quasispecies
S Franco, M Parera, E Aparicio. et al
(14 CROI)
PDF Poster Abstract

POSTER
Analysis of the Hepatitis C Virus Antigen-specific T-cell Receptor Repertoire during Acute Infection
E Patterson, A Cox, S Ray
(14 CROI)
PDF Poster Abstract

Natural History/Clinical Course

Journal Papers, Abstracts, and Commentaries

Ethnicity and Body Mass Index are Associated with Hepatitis C Presentation and
Progression.
Kallwitz ER, Layden-Almer J, Dhamija M, et al
Clin Gastroenterol Hepatol. 2009 Aug 14
Abstract

The natural history of recurrent hepatitis C and what influences this.
Gane EJ.
Liver Transpl. 2008 Oct;14 Suppl 2:S36-44
Abstract

Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.
Missiha SB, Ostrowski M, Heathcote EJ.
Gastroenterology. 2008 May;134(6):1699-714
Abstract

Clinical course of hepatitis C virus infection in renal transplant recipients.
Savas N, Ocal S, Colak T, et al
Transplant Proc. 2007 May;39(4):984-6.
Abstract

FULL-TEXT ARTICLE
The natural history of hepatitis C virus (HCV) infection.
Chen SL, Morgan TR.
Int J Med Sci. 2006;3(2):47-52.
Paper

Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to
hepatocellular carcinoma.
Leone N, Rizzetto M.
Minerva Gastroenterol Dietol. 2005 Mar;51(1):31-46.
Abstract

Hepatitis C and Progression of HIV Disease.
Sulkowski MS, Moore RD, Mehta SH, et al.
JAMA 2002 Jul 10;288(2):199-206
Abstract

Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the
natural course of hepatitis C virus infection in the general population.
Kondili LA, Chionne P, Costantino A, et al
Gut 2002 May;50(5):693-6
Abstract

FULL-TEXT ARTICLE
Clinical course of hepatitis C virus during the first decade of infection: cohort study
Harris HW, Ramsay ME, Andrews N, Eldridge KP
BMJ 2002; 324: 450.
Paper

Is severe liver disease a common outcome for people with chronic hepatitis C?
Dore GJ, Freeman AJ, Law M, Kaldor J.
J Gastroenterol Hepatol 2002 Apr;17(4):423-30
Abstract

Conference Reports, Abstracts, and Posters

	CONFERENCE PRESENTATION The Course and Outcome of Hepatitis C Hoofnagle JH [NIH Consensus Development Conference on Management of Hepatitis C: 2002] Report

	CONFERENCE PRESENTATION Natural History of Chronic Hepatitis C Seeff LB [NIH Consensus Development Conference on Management of Hepatitis C: 2002] Report

Patient Perspectives

Journal Papers, Abstracts, and Commentaries

Quality-of-Life Tradeoffs for Hepatitis C Treatment: Do Patients and Providers Agree?
Schackman BR, Teixeira PA, Weitzman G, et al
Med Decis Making. 2008 Mar 18 |
Abstract

Communicating about Alcohol Consumption to Nonharmful Drinkers with Hepatitis C:
Patient and Provider Perspectives.
Blixen CE, Webster NJ, Hund AJ, et al
J Gen Intern Med. 2008 Jan
Abstract

What do patients consider when making decisions about treatment for hepatitis C?
Fraenkel L, McGraw S, Wongcharatrawee S, et al
Am J Med. 2005 Dec;118(12):1387-91.
Abstract

Conference Reports, Abstracts, and Posters

	CONFERENCE PRESENTATION The Course and Outcome of Hepatitis C Hoofnagle JH [NIH Consensus Development Conference on Management of Hepatitis C: 2002] Report

	CONFERENCE PRESENTATION Natural History of Chronic Hepatitis C Seeff LB [NIH Consensus Development Conference on Management of Hepatitis C: 2002] Report

Quality of Life

Journal Papers, Abstracts, and Commentaries

Sustained Responders Have Better Quality of Life and Productivity Compared With
Treatment Failures Long After Antiviral Therapy for Hepatitis C.
John-Baptiste AA, Tomlinson G, Hsu PC, et al
Am J Gastroenterol. 2009 Jun 30.
Abstract

Quality-of-Life Tradeoffs for Hepatitis C Treatment: Do Patients and Providers Agree?
Schackman BR, Teixeira PA, Weitzman G, et a
Med Decis Making. 2008 Mar 18
Abstract

Alcohol and Sexual HIV Risk Behavior Among Problem Drinking Men Who Have Sex With Men:
An Event Level Analysis of Timeline Followback Data.
Irwin TW, Morgenstern J, Parsons JT, et al
AIDS Behav. 2006 Feb 16;
Abstract

Vaccinations

Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE
Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections:
A review of the evidence and current recommendations.
Buxton JA, Kim JH.
Can J Infect Dis Med Microbiol. 2008 Mar;19(2):197-202
Paper

Home Page Main New/Newsworthy Disease Index

Hepatitis C Main Page

January 2010

Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent
hepatitis C after liver transplantation.
Hashimoto K, Miller C, Hirose K, et alClin Transplant. 2009 Dec 28

Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women
and perinatal transmission to infants in Thailand.
Ngo-Giang-Huong N, Jourdain G, Sirirungsi W,et al Int J Infect Dis. 2010 Jan 2

Hepatitis C and diabetes: one treatment for two diseases?
Pattullo V, Heathcote J.Liver Int. 2009 Dec 22.

Non-invasive evaluation of the fibrosis stage in chronic hepatitis C:
a comparative analysis of nine scoring methods.
Ladero JM, Delkader J, Ortega L, et al Scand J Gastroenterol. 2010;45(1):51-9.

Program characteristics associated with testing for HIV and hepatitis C in veterans
substance use disorder clinics.
McInnes DK, Hyun JK, Trafton JA, et alPsychiatr Serv. 2010 Jan;61(1):90-4.

Reducing treatment duration in patients infected with hepatitis C genotype 1:
any need for further studies?
Crax� A.Antivir Ther. 2009;14(8):1045-9.

Optimal length of antiviral therapy in patients with hepatitis C virus
genotypes 2 and 3: a meta-analysis.
Slavenburg S, Weggelaar I, van Oijen MG, Drenth JP.Antivir Ther. 2009;14(8):1139-48.

On-treatment predictions of success in peg-interferon/ribavirin treatment
using a novel formula.
Saito H, Ebinuma H, Ojiro K, et al World J Gastroenterol. 2010 Jan 7;16(1):89-97.

New opportunities for the management and therapy of hepatitis C in correctional settings.
Martin CK, Hostetter JE, Hagan JJ. Am J Public Health. 2010 Jan;100(1):13-7.

Program Characteristics Associated With Testing for HIV and Hepatitis C in Veterans
Substance Use Disorder Clinics.
McInnes DK, Hyun JK, Trafton JA,et al Psychiatr Serv. 2010 Jan;61(1):90-94.

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL, van de Vijver DA, Hezka J, et al J Med Virol. 2010 Feb;82(2):263-270.

Hepatitis C virus recombinants are rare even among intravenous drug users.
Viazov S, Ross SS, Kyuregyan KK, et al J Med Virol. 2010 Feb;82(2):232-8.

Guidelines

Internet Documents

FULL-TEXT GUIDELINES
Chronic Hepatitis C: Current Disease Management
The National Institute of Diabetes and Digestive and Kidney Diseases
Guidelines

Hepatitis C: What Clinicians and Other Health Professionals Need to Know
Training Module

Conference Reports, Abstracts, and Posters

CONFERENCE PRESENTATION
Draft NIH Consensus Statement on the Management of Hepatitis C
[NIH Consensus Development Conference on Management of Hepatitis C: 2002]
Report

General Reports

Internet Documents
	FULL-TEXT REPORT An Interview with Melissa Palmer, MD on her book, Dr. Melissa Palmer's Guide to Hepatitis & Liver Disease. Nary G Thoughtleaders August 2004 Vo 2 No 1 Interview